Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction: The Global Approach to Lowering Adverse Cardiac Outcomes Through Improving Contractility in Heart Failure (GALACTIC-HF) Trial
Publication
, Conference
Teerlink, JR; Diaz, R; Felker, GM; Metra, M; McMurray, JJ; Solomon, SD; Sharpsten, LA; Legg, JC; Abbasi, SA; Malik, FI; Kurtz, CE ...
Published in: CIRCULATION
December 15, 2020
Duke Scholars
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
December 15, 2020
Volume
142
Issue
24
Start / End Page
E481 / E482
Related Subject Headings
- Cardiovascular System & Hematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Teerlink, J. R., Diaz, R., Felker, G. M., Metra, M., McMurray, J. J., Solomon, S. D., … Investigators, G.-H. (2020). Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction: The Global Approach to Lowering Adverse Cardiac Outcomes Through Improving Contractility in Heart Failure (GALACTIC-HF) Trial. In CIRCULATION (Vol. 142, pp. E481–E482).
Teerlink, John R., Rafael Diaz, G Michael Felker, Marco Metra, John J. McMurray, Scott D. Solomon, Lucie A. Sharpsten, et al. “Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction: The Global Approach to Lowering Adverse Cardiac Outcomes Through Improving Contractility in Heart Failure (GALACTIC-HF) Trial.” In CIRCULATION, 142:E481–82, 2020.
Teerlink JR, Diaz R, Felker GM, Metra M, McMurray JJ, Solomon SD, et al. Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction: The Global Approach to Lowering Adverse Cardiac Outcomes Through Improving Contractility in Heart Failure (GALACTIC-HF) Trial. In: CIRCULATION. 2020. p. E481–2.
Teerlink, John R., et al. “Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction: The Global Approach to Lowering Adverse Cardiac Outcomes Through Improving Contractility in Heart Failure (GALACTIC-HF) Trial.” CIRCULATION, vol. 142, no. 24, 2020, pp. E481–82.
Teerlink JR, Diaz R, Felker GM, Metra M, McMurray JJ, Solomon SD, Sharpsten LA, Legg JC, Abbasi SA, Malik FI, Kurtz CE, Investigators GALACTIC-HFC. Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction: The Global Approach to Lowering Adverse Cardiac Outcomes Through Improving Contractility in Heart Failure (GALACTIC-HF) Trial. CIRCULATION. 2020. p. E481–E482.
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
December 15, 2020
Volume
142
Issue
24
Start / End Page
E481 / E482
Related Subject Headings
- Cardiovascular System & Hematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology